Rieger F. Trials of arsenic trioxide therapy should be envisioned for severely respiratory distress syndrome related to a cytokine storm in COVID-19 patients. Jpn. j. res. [Internet]. 2023 Apr. 17 [cited 2024 Sep. 22];2(1). Available from: https://journals.sciencexcel.com/index.php/jjr/article/view/26